William Grossman
Net worth: 7 806 $ as of 2026-10-30
Net worth: 7 806 $ as of 2026-10-30
William Grossman is the founder of Children's Hospital of Wisconsin, Inc. Current positions include Director at Tizona Therapeutics, Inc. and Director at Pionyr Immunotherapeutics, Inc. Former positions include Group Director-Medical at Genentech, Inc. from 2015 to 2018; Director at Bryologyx, Inc.; Independent Director at Day One Biopharmaceuticals, Inc. from 2024 to 2026; Director & Chief Medical Officer at enGene Therapeutics, Inc. in 2026; Senior Vice President, Head-Research & Development at Biothera, Inc. from 2011 to 2013; Chief Medical Officer at Bellicum Pharmaceuticals, Inc. from 2018 to 2019; Professor at The Medical College of Wisconsin, Inc.; Senior VP-Oncology Clinical Development at Gilead Sciences, Inc. from 2021 to 2024; and Chief Medical Officer at Arcus Biosciences, Inc. from 2019 to 2021.
Education includes undergraduate studies at the University of St. Thomas and a doctorate from Washington University School of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-21 | 5,102 ( 0.01% ) | 7 806 $ | 2026-10-30 |
| Companies | Position | Start |
|---|---|---|
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Director/Board Member | - |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2026-11-08 |
| DAY ONE BIOPHARMACEUTICALS, INC. | Director/Board Member | 2026-04-22 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2024-07-31 |
Bryologyx, Inc.
Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Director/Board Member | 2021-12-20 |
| ARCUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-07-15 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 14 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
University of St. Thomas
University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Medical College of Wisconsin, Inc.
The Medical College of Wisconsin, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Children's Hospital of Wisconsin, Inc.
Children's Hospital of Wisconsin, Inc. Hospital/Nursing ManagementHealth Services Operates as children's hospital | Health Services |
Washington University School of Medicine
Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Health Technology |
Bryologyx, Inc.
Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
enGene Holdings, Inc.
enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions